1Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Center, Tampere University, Tampere, Finland.

This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license This work ...

Fred Hutch Cancer Center in Seattle, WA, terminated its diversity, equity, and inclusion (DEI) initiatives due to President Donald Trump’s executive order threatening to withhold funding to federal ...

Mirdametinib earned FDA approval for the treatment of inoperable plexiform neurofibromas associated with neurofibromatosis type 1, marking the first on-label option for adults. The decision highlights ...

Major Finding: A recombinant Newcastle disease virus engineered to induce hyperacute rejection inhibited tumor growth a clinical trial. Concept: NDV-GT is an engineered oncolytic virus that induces ...

Copyright held by the owner/author(s). This open access article is distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license Newly ...

A small clinical trial of a peptide-based personalized vaccine found that it elicited robust immune responses and prevented relapse in patients who have undergone surgery for renal cell carcinoma. Now ...

Major Finding: HIV Nef expression reduces allorecognition and apoptotic cell death of CAR T cells. Concept: Controlled Nef expression reduces HLA-I levels and protects CAR T cells from CD8 + T cell– ...

1Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota. *Corresponding Author: Jann N. Sarkaria, Department of Radiation Oncology, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905.

At today’s Senate Health, Education, Labor, and Pensions Committee hearing, nominee for Secretary of the Department of Health and Human Services Robert F. Kennedy (RFK) Jr. refused to renounce his ...